Bernstein lowered the firm’s price target on UnitedHealth (UNH) to $337 from $377 and keeps an Outperform rating on the shares. The firm reduced estimates post the Q2 report to reflect the company’s’ lower earnings power base in 2025. However, it remains positive on UnitedHealth’s earnings growth, driven by a turnaround for both the company and sector.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH: